VarsaAI Launches VeriCore™ — The World's First Scientific Content Verification System

VeriCore™ represents a category-defining breakthrough in how science is communicated, transforming AI-generated content from generic output into trusted, verified science storytelling that is ready for MLR approval within minutes.

For decades, the pharmaceutical industry has operated under a fundamental constraint: the gap between clinical data and HCP communication. Trial results arrive. New drugs receive approval. Vaccines reach regulatory clearance. And then months pass while Medical Affairs teams navigate the content creation and review cycle before a single HCP or field representative is equipped with the science they need.

VeriCore™ changes that.

"The accuracy barrier has been the unlock that has held science back," said Florence Holliday, Co-Founder of VarsaAI. "Every pharmaceutical company knows the science before their HCPs do. VeriCore™ closes that gap — not by cutting corners on accuracy, but by making verified, MLR-ready content available in minutes rather than months. This is how AI genuinely accelerates the journey from innovation to patient."

How VeriCore™ Works

VeriCore™ is a mandatory verification layer embedded at the foundation of every VarsaAI content generation. Before a single word is written or frame rendered, VeriCore™ extracts every scientific entity in the content brief and cross-references it against the world's leading life sciences databases — including the RCSB Protein Data Bank, UniProt, Reactome, KEGG, WHO INN, and FDA Label data.

Only when every entity passes the VeriCore™ authenticity gate does content generation begin. Every output is accompanied by a structured audit record — source citations, confidence classifications, and human expert review flags — designed to be submitted directly alongside the content asset in MLR review.

The result: content that has historically taken six to twelve weeks from data to approval-ready output now reaches MLR-ready standard in minutes, compressing the review process from weeks to hours.

A Category-Defining Moment for Pharmaceutical AI

VeriCore™ marks a fundamental shift in what AI can deliver for regulated industries. Until now, AI content generation and scientific accuracy have been in tension — pharmaceutical companies unwilling to deploy AI at scale because no platform could provide the verification standard their MLR process demands.

VarsaAI resolves that tension permanently.

"We are not building faster content tools," added Florence. "We are building the infrastructure that gets drugs and vaccines to market months faster by eliminating the content bottleneck between clinical data and HCP knowledge. VeriCore™ is the proof that cutting-edge AI and scientific rigour are not a trade-off. They are the same thing."

About VarsaAI

VarsaAI is the AI-powered scientific content platform built exclusively for pharmaceutical and life sciences companies. Underpinned by VeriCore™ — the world's first scientific content verification system — VarsaAI enables Medical Affairs, Scientific Communications, and Field Training teams to produce verified MOA videos, HCP explainers, congress leave-behinds, and field training materials in minutes. VarsaAI is built on Claude (Anthropic) and operates in full compliance with GDPR and life sciences data standards.